Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026)
Emergent BioSolutions (EBS) posted quarterly Treasury Shares of $261.6 million for Q1 2026, up 14.89% year-over-year from $227.7 million in Q1 2025, and up 3.56% quarter-over-quarter from $252.6 million in Q4 2025.
Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026) Analysis & Trends
Emergent BioSolutions' Treasury Shares history runs 15 years deep, the most recent figure standing at $261.6 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 14.89% year-over-year to $261.6 million; the TTM figure through Mar 2026 stood at $261.6 million (up 14.89% YoY), while the FY2025 annual figure was $252.6 million, up 10.94% from the prior year.
- Treasury Shares for Q1 2026 stood at $261.6 million, up from $252.6 million in the prior quarter.
- The five-year high for Treasury Shares was $9.6 million in Q1 2026, with the low at $4.9 million in Q1 2022.
- The 5-year median for Treasury Shares is $5.6 million (2022), against an average of $6.2 million.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares surged 475.0% in 2022, then changed 0.0% in 2023.
- Emergent BioSolutions' Treasury Shares stood at $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then gained by 10.94% to $252.6 million in 2025, then climbed by 3.56% to $261.6 million in 2026.
- Business Quant data shows EBS's Treasury Shares at $261.6 million in Q1 2026, $252.6 million in Q4 2025, and $243.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.90 Bn | 40.24 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 32.45 Bn | 30.78 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 19.00 Mn |
| 10 | Emergent BioSolutions | 253.30 Mn | 112.40 Mn | 137.20 Mn | 10.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270.50 Mn |
| Jun 30, 2026 | 10.70 Mn |
| Jun 30, 2026 | 10.70 Mn |
| Jun 30, 2026 | 270.50 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Mar 31, 2026 | 261.60 Mn |
| Mar 31, 2026 | 261.60 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Dec 31, 2025 | 252.60 Mn |
| Dec 31, 2025 | 252.60 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 243.50 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Sep 30, 2025 | 243.50 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Jun 30, 2025 | 234.60 Mn |
| Jun 30, 2025 | 234.60 Mn |
| Jun 30, 2025 | 6.70 Mn |